Austria vs Madagascar: Previously treated cases tested for RR-/MDR-TB
Austria
61.0%
in 2024
Madagascar
69.0%
in 2024
Austria rank
136th
Madagascar rank
134th
Previously treated cases tested for RR-/MDR-TB over time
- Austria
- Madagascar
How they compare
Madagascar currently reports 69.0% against 61.0% in Austria, a difference of 8.0%.
That makes Madagascar's figure about 1.1 times Austria's.
The two have swapped places 5 times across 18 shared years of data; in 2006 it was Austria ahead.
Austria ranks 136th and Madagascar ranks 134th of 180 countries.
Across the 3 decades both report, Austria averaged higher in 2 and Madagascar in 1.
Head to head by decade
| Decade | Austria | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.3% | 1.6% | 43.8% | Austria |
| 2010s | 58.6% | 18.3% | 40.3% | Austria |
| 2020s | 54.4% | 56.0% | 1.6% | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Austria or Madagascar?
- Madagascar, at 69.0% against 61.0% in Austria as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Austria and Madagascar?
- 8.0%, with Madagascar ahead.
- How many years of comparable data are there for Austria and Madagascar?
- 18 years are reported by both, from 2006 to 2024.
- How do Austria and Madagascar rank globally for previously treated cases tested for rr-/mdr-tb?
- Austria ranks 136th and Madagascar ranks 134th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.